You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for Patent: 8,497,378


✉ Email this page to a colleague

« Back to Dashboard


Title:Process for making quinolone compounds
Abstract: The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.
Inventor(s): Hanselmann; Roger (Branford, CT), Reeve; Maxwell M. (Guilford, CT), Johnson; Graham (Madison, CT)
Assignee: Rib-X Pharmaceuticals, Inc. (New Haven, CT)
Filing Date:Sep 23, 2009
Application Number:13/120,278
Claims:1. A process for preparing a quinolone compound comprising the step of reacting a des-chloro quinolone compound or a pharmaceutically acceptable salt or ester thereof with a chlorinating agent and an acid, wherein the molar ratio of the acid to des-chloro quinolone is from about 0.007 to about 0.02, wherein less than about 0.40% of dimeric impurity on an area percent basis of the quinolone is produced.

2. A process according to claim 1 wherein the quinolone compound is 1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetid- in-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt or ester thereof and the des-chloro quinolone compound is 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-hydroxy-azetidin-1-yl)- -4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt or ester thereof.

3. A process according to claim 2 wherein the dimeric impurity is 1-Amino-3-(azetidin-3-yloxy)-propan-2-ol-bis(N,N'-quinolone carboxylic acid), or a pharmaceutically acceptable salt or ester thereof.

4. A process according to claim 1 wherein the chlorinating agent is N-chlorosuccinimide.

5. A process according to claim 1 wherein the acid is selected from the group consisting of sulfuric acid, hydrochloric acid, hydrobromic acid, phosphoric acid, trifluoroacetic acid, triflic acid, methanesulfonic acid, p-toluenesulfonic acid, or perchloric acid, and mixtures thereof.

6. A process according to claim 1 wherein the acid is sulfuric acid.

7. A process according to claim 1 where the reaction is run at a temperature from about 0.degree. C. to about 30.degree. C.

8. A process according to claim 1 wherein the molar ratio of N-chlorosuccinimide to des-chloro quinolone is greater than about 1.

9. A process according to claim 1 using an acetate ester as a solvent.

10. A process according to claim 9 wherein said acetate ester is selected from the group consisting of methyl acetate, ethyl acetate, and mixtures thereof.

11. A process according to claim 9 wherein said acetate ester is methyl acetate.

12. A process according to claim 1 comprising the further step of reacting the quinolone compound with a base.

13. A process according to claim 12 wherein the base is a hydroxide base.

14. A process according to claim 13 wherein the hydroxide base is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide, barium hydroxide, and mixtures thereof.

15. A process according to claim 14 wherein the hydroxide base is potassium hydroxide.

16. A process according to claim 12 using a mixture of isopropanol and water as a solvent.

17. A process according to claim 1 wherein said process is a commercial scale process.

18. A composition comprising the quinolone compound 1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetid- in-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt or ester thereof having less than about 0.40% of the compound 1-Amino-3-(azetidin-3-yloxy)-propan-2-ol-bis(N,N'-quinolone carboxylic acid), or a pharmaceutically acceptable salt or ester thereof.

19. A composition according to claim 18 wherein said composition is a commercial scale composition.

20. The process of claim 1 or 2, wherein the molar ratio of chlorinating agent to des-chloro quinolone is from about 1.05 to about 1.2.

21. The process of claim 1 or 2, wherein the molar ratio of chlorinating agent to des-chloro quinolone is from about 1.04 to about 1.07.

22. The process of claim 1 or 2, wherein the molar ratio of acid to des-chloro quinolone is from about 0.008 to about 0.012.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.